Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 150,000 | $2.93 | $439,500.00 |
DisclosureSEC source: 0001937915-25-000010 · form4-12032025_101208.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 22:55 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · derivative · entry 6 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,000 Underlying: Class A Common Stock · 10,000 shares Expires 2032-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 22:55 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 10,000 | $8.00 | $80,000.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 4 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 22:55 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 10,000 | $3.61 | $36,100.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 22:55 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · derivative · entry 5 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,000 Underlying: Class A Common Stock · 10,000 shares Expires 2032-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 22:55 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 10,000 | $7.50 | $75,000.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 22:55 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 10,000 | $3.61 | $36,100.00 |
DisclosureSEC source: 0001937915-25-000008 · form4-11262025_101117.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001521111-25-000006 · form4-11242025_091137.xml · derivative · entry 6 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Class A Common Stock · 300,000 shares Expires 2033-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options vested as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 69,051 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001521111-25-000006 · form4-11242025_091137.xml · derivative · entry 5 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,884 Underlying: Class A Common Stock · 69,051 shares Expires 2030-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vested as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
SaleClass A Common Stock | 300,000 | $7.23 | $2,168,100.00 |
DisclosureSEC source: 0001521111-25-000006 · form4-11242025_091137.xml · nonDerivative · entry 4 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionClass A Common Stock | 300,000 | $1.94 | $582,000.00 |
DisclosureSEC source: 0001521111-25-000006 · form4-11242025_091137.xml · nonDerivative · entry 3 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
SaleClass A Common Stock | 69,051 | $7.23 | $499,031.58 |
DisclosureSEC source: 0001521111-25-000006 · form4-11242025_091137.xml · nonDerivative · entry 2 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:09 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionClass A Common Stock | 69,051 | $1.74 | $120,148.74 |
DisclosureSEC source: 0001521111-25-000006 · form4-11242025_091137.xml · nonDerivative · entry 1 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:08 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001937915-25-000006 · form4-11242025_091135.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Class A Common Stock · 20,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:08 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 20,000 | $7.00 | $140,074.00 |
DisclosureSEC source: 0001937915-25-000006 · form4-11242025_091135.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 F1 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.00 to $7.005. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:08 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 20,000 | $1.87 | $37,400.00 |
DisclosureSEC source: 0001937915-25-000006 · form4-11242025_091135.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 21:47 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · derivative · entry 6 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 21:47 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 15,000 | $5.10 | $76,552.50 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 4 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.21. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 3,000 shares acquired on November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 21:47 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 15,000 | $1.87 | $28,050.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 16:05 UTC |
Hanley David C.CHIEF TECHNICAL OPERATIONS
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001865826-25-000004 · form4-11212025_091102.xml · derivative · entry 3 Hanley David C. · CIK 0001865826 · CHIEF TECHNICAL OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Class A Common Stock · 200,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 16:05 UTC |
Hanley David C.CHIEF TECHNICAL OPERATIONS
|
SaleClass A Common Stock | 200,000 | $7.14 | $1,427,680.00 |
DisclosureSEC source: 0001865826-25-000004 · form4-11212025_091102.xml · nonDerivative · entry 2 Hanley David C. · CIK 0001865826 · CHIEF TECHNICAL OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.045 to $7.260. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 16:05 UTC |
Hanley David C.CHIEF TECHNICAL OPERATIONS
|
Exercise / conversionClass A Common Stock | 200,000 | $1.87 | $374,000.00 |
DisclosureSEC source: 0001865826-25-000004 · form4-11212025_091102.xml · nonDerivative · entry 1 Hanley David C. · CIK 0001865826 · CHIEF TECHNICAL OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,000 shares acquired on each of May 19, 2025 and November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:47 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · derivative · entry 5 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:47 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 15,000 | $4.77 | $71,475.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:47 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 15,000 | $1.87 | $28,050.00 |
DisclosureSEC source: 0001937915-25-000004 · form4-11192025_091127.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 20:24 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001521111-25-000003 · form4-10292025_081026.xml · derivative · entry 3 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298,935 Underlying: Class A Common Stock · 100,000 shares Expires 2030-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 20:24 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
SaleClass A Common Stock | 100,000 | $5.02 | $502,460.00 |
DisclosureSEC source: 0001521111-25-000003 · form4-10292025_081026.xml · nonDerivative · entry 2 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated June 24, 2024. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 20:24 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionClass A Common Stock | 100,000 | $1.74 | $174,000.00 |
DisclosureSEC source: 0001521111-25-000003 · form4-10292025_081026.xml · nonDerivative · entry 1 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:30 UTC |
Mashal RobertDirector
|
GiftStock Option (Right to buy) · Derivative | 350,001 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001415889-25-021652 · form4-08132025_080809.xml · derivative · entry 2 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 350,001 Underlying: Class A Common Stock · 350,001 shares Expires 2034-01-07 F1 · derivative.exercise_date: The shares underlying the option are fully vested. F2 · ownership.direct: The reported transaction involves the reporting person's transfer of option to his irrevocable trust. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:30 UTC |
Mashal RobertDirector
|
GiftStock Option (Right to Buy) · Derivative | 350,001 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001415889-25-021652 · form4-08132025_080809.xml · derivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,178 Underlying: Class A Common Stock · 350,001 shares Expires 2034-01-07 F1 · derivative.exercise_date: The shares underlying the option are fully vested. F2 · ownership.direct: The reported transaction involves the reporting person's transfer of option to his irrevocable trust. Read SEC document |
| June 18, 2025 Filed Jun 18, 2025 20:05 UTC |
Markel StacyCHIEF PEOPLE OFFICER
|
PurchaseClass A Common Stock | 10,000 | $1.71 | $17,100.00 |
DisclosureSEC source: 0001415889-25-017660 · form4-06182025_040613.xml · nonDerivative · entry 1 Markel Stacy · CIK 0001734780 · CHIEF PEOPLE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,591 F1 · balance_after: Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:05 UTC |
Sauvage PhilippeChief Financial Officer
|
PurchaseClass A Common Stock | 4,000 | $1.79 | $7,160.00 |
DisclosureSEC source: 0001415889-25-017659 · form4-06182025_040610.xml · nonDerivative · entry 2 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,902 Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC |
Sauvage PhilippeChief Financial Officer
|
PurchaseClass A Common Stock | 3,300 | $1.84 | $6,055.50 |
DisclosureSEC source: 0001415889-25-017659 · form4-06182025_040610.xml · nonDerivative · entry 1 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,902 F1 · balance_after: Includes 2,602 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 16:05 UTC |
Sjogren ColleenChief Commercial Officer
|
PurchaseClass A Common Stock | 50,000 | $1.81 | $90,350.00 |
DisclosureSEC source: 0001415889-25-017658 · form4-06182025_040607.xml · nonDerivative · entry 1 Sjogren Colleen · CIK 0002017751 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,000 F1 · price: The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.795 to $1.82, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
PurchaseClass A Common Stock | 24,000 | $1.80 | $43,200.00 |
DisclosureSEC source: 0001415889-25-017657 · form4-06182025_040604.xml · nonDerivative · entry 2 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
PurchaseClass A Common Stock | 26,000 | $1.79 | $46,540.00 |
DisclosureSEC source: 0001415889-25-017657 · form4-06182025_040604.xml · nonDerivative · entry 1 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC |
Hung DavidDirector · PRESIDENT AND CEO · 10% owner
|
PurchaseClass A Common Stock | 500,000 | $1.79 | $893,500.00 |
DisclosureSEC source: 0001415889-25-017656 · form4-06182025_040601.xml · nonDerivative · entry 1 Hung David · CIK 0001310880 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,281,054 F1 · price: ) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.88, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC |
Mashal RobertDirector
|
GrantStock Option (Right to Buy) · Derivative | 292,983 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001415889-25-014420 · form4-05232025_040508.xml · derivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,983 Underlying: Class A Common Stock · 292,983 shares Expires 2035-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 292,983 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001415889-25-014418 · form4-05232025_040506.xml · derivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,983 Underlying: Class A Common Stock · 292,983 shares Expires 2035-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC |
VERNON W ANTHONYDirector
|
GrantStock Option (Right to Buy) · Derivative | 292,983 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001415889-25-014421 · form4-05232025_040510.xml · derivative · entry 1 VERNON W ANTHONY · CIK 0001369091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,983 Underlying: Class A Common Stock · 292,983 shares Expires 2035-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC |
BLICKENSTAFF KIM DDirector
|
GrantStock Option (Right to Buy) · Derivative | 292,983 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001415889-25-014417 · form4-05232025_040503.xml · derivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,983 Underlying: Class A Common Stock · 292,983 shares Expires 2035-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC |
Bazemore Robert BDirector
|
GrantStock Option (Right to Buy) · Derivative | 292,983 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001415889-25-014416 · form4-05232025_040501.xml · derivative · entry 1 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,983 Underlying: Class A Common Stock · 292,983 shares Expires 2035-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:05 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $1.94 Strike: $1.94 | $38,800.00 |
DisclosureSEC source: 0001415889-25-012096 · form4-05062025_040501.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,000 Underlying: Class A Common Stock · 20,000 shares Expires 2033-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on 2/28/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:05 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 20,000 | $2.50 | $50,024.00 |
DisclosureSEC source: 0001415889-25-012096 · form4-05062025_040501.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated October 10, 2024. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.50 to $2.505. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2025 Filed May 6, 2025 20:05 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 20,000 | $1.94 | $38,800.00 |
DisclosureSEC source: 0001415889-25-012096 · form4-05062025_040501.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 01:30 UTC |
Hung DavidDirector · PRESIDENT AND CEO · 10% owner
|
PurchaseClass A Common Stock | 300,000 | $1.63 | $487,500.00 |
DisclosureSEC source: 0001415889-25-010446 · form4-04092025_010447.xml · nonDerivative · entry 2 Hung David · CIK 0001310880 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,781,054 F2 · price: ) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 04, 2025 Filed Apr 9, 2025 01:30 UTC |
Hung DavidDirector · PRESIDENT AND CEO · 10% owner
|
PurchaseClass A Common Stock | 200,000 | $1.66 | $332,720.00 |
DisclosureSEC source: 0001415889-25-010446 · form4-04092025_010447.xml · nonDerivative · entry 1 Hung David · CIK 0001310880 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,481,054 F1 · price: The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.6499 to $1.6699, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:05 UTC |
Mashal RobertDirector
|
PurchaseClass A Common Stock | 98,900 | $1.67 | $165,153.11 |
DisclosureSEC source: 0001415889-25-009908 · form4-04032025_040403.xml · nonDerivative · entry 2 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 200,000 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:05 UTC |
Mashal RobertDirector
|
PurchaseClass A Common Stock | 1,100 | $1.67 | $1,832.05 |
DisclosureSEC source: 0001415889-25-009908 · form4-04032025_040403.xml · nonDerivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 101,100 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 23:35 UTC |
Sauvage PhilippeChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001415889-25-006701 · form4-03042025_110353.xml · derivative · entry 1 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Class A Common Stock · 500,000 shares Expires 2035-02-27 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.